youtube_live
Q3 2026 earnings • released • Revenue beat +35,39%
See resultschevron_right
SDGR:NASDAQ
Schrodinger Inc
28,77 USD
arrow_upward
+0,88%(+0,25) 1D
28,51 USD
arrow_downward
-0,90% (-0,26)todayPre-market
Closed: 5-ноя., 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SDGR...
Open
29,10 USD
High
30,09 USD
Low
27,16 USD
Mkt. cap
2,15 млд
Avg. vol.
2,32 млн
Volume
8,18 миң
52-wk high
33,78 USD
52-wk low
10,95 USD
EPS
-0,74 USD
Beta
1,69
Shares outstanding
65,64 млн
No. of employees
850
Open
29,10 USD
High
30,09 USD
Low
27,16 USD
Mkt. cap
2,15 млд
Avg. vol.
2,32 млн
Volume
8,18 миң
52-wk high
33,78 USD
52-wk low
10,95 USD
EPS
-0,74 USD
Beta
1,69
Shares outstanding
65,64 млн
No. of employees
850
News stories
From web sources and news partners
Zacks
·
1 күн мурун
Schrodinger, Inc. (SDGR) Reports Q3 Loss, Beats Revenue Estimates
Securities.io
·
1 күн мурун
Schrödinger Raises 2026 Outlook as Q3 Revenue Grows 19%
Benzinga
·
1 күн мурун
Schrodinger Q3 2026 Earnings Call Transcript
Profile
Schrödinger, Inc. is an international scientific software and biotechnology company that specializes in developing computational tools and software for drug discovery and materials science.
Schrödinger's software is used by pharmaceutical companies, biotech, tech, chemicals, energy, aerospace firms, and academic researchers to simulate and model the behavior of molecules at the atomic level. This accelerates the design and develops new drugs and materials more efficiently, reducing the time and cost of bringing them to market.
Schrödinger's software tools include molecular dynamics simulations, free energy calculations, quantum mechanics calculations, and virtual screening tools. The company also offers consulting services and collaborates with partners in the industry to advance the field of computational chemistry and drug discovery. Wikipedia
About Schrodinger Inc